NEW YORK (GenomeWeb News) – An international group of collaborators from academia and the business sector will partner to use integrative systems biology and comparative genomics approaches to study age-related human brain diseases with a particular focus on discovering new molecular targets and biomarkers for late-onset Alzheimer's disease.

The AgedBrainSYSBIO project, which is funded with €6 million ($7.7 million) from the European Commission, includes 14 partners in Belgium, France, Estonia, Germany, Israel, the UK, and Switzerland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.